NetworkNewsBreaks Archive - Page 1360 of 2151

FridayAug 28, 2020 9:38 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Second Eye-Net Pilot with Japanese Multinational Company

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., will start a pilot project with a multibillion, multinational Japanese electronics company to test its Eye-Net(TM) Protect cellular-based vehicle-to-everything (“V2X”) accident prevention solution. This is the second pilot project Foresight announced this month, following first with a multibillion global Japanese technology company to test Eye-Net Mobile's solution. “This second pilot project is a vote of confidence from another Japanese company that reinforces our market penetration strategy, targeting the smart devices and services market, including dashcams, head-up displays,…

ThursdayAug 27, 2020 3:02 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (PCSA) Enters Exclusive Agreement to Expand Pipeline, Oncology Involvement

Processa Pharmaceuticals (OTCQB: PCSA), today announced its entry into a contingent precedent exclusive licensing agreement with Elion Oncology Inc. to develop, manufacture and commercialize eniluracil (“PCS6422”) globally. According to the update, PCS6422 is an oral drug designed to be administered with fluoropyrimidine cancer drugs (i.e., “capecitabine,” “5-FU”) in order to decrease their breakdown to inactive metabolites or metabolites known to cause unwanted side effects and interfere with the anticancer activity. “Having worked on 5-FU and other cancer agents in the past, adding PCS6422 to our pipeline and expanding our involvement in oncology was an easy decision given the significant impact…

ThursdayAug 27, 2020 2:35 pm

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) to Offer Esketamine for Treatment of Adults with MDD at Flagship Clinic

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), today announced that it is expanding its rapid-onset treatment service for major depressive disorder (“MDD”). According to the update, Champignon will offer esketamine for the treatment of adults with MDD at its flagship clinic, the Canadian Rapid Treatment Centre of Excellence (“CRTCE”), starting in September 2020. Declared a breakthrough treatment for depression by the US Food and Drug Administration (“FDA”), esketamine was approved by Health Canada for the treatment of MDD in May 2020. “The availability of esketamine at the CRTCE provides tremendous opportunity for adults across Canada affected by treatment-resistant depression…

ThursdayAug 27, 2020 1:03 pm

NetworkNewsBreaks – ISW Holdings Inc. (ISWH) Bit5ive Partnership Is ‘Big Deal for ISWH Shares’

ISW Holdings (OTC: ISWH), a global brand-management portfolio company with diverse partnerships, is entering a promising new space just in time for the revolution in turnkey crypto-mining solutions (http://nnw.fm/c2u6D). A recent article discussing this covers a TradingView report that highlights the company’s opportunity and optimal timing through a recent collaboration it deems a “big deal for ISWH shares.” The piece reads, “ISW Holdings Inc. has entered the crypto-mining equipment industry by virtue of its recent joint venture partnership with Bit5ive LLC, a global top player in the space developing, running and selling what are known as ‘turnkey mining solutions.’ This…

ThursdayAug 27, 2020 12:41 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) and TumorGenesis Advancing Path Toward Patient-Specific Treatments

Predictive Oncology (NASDAQ: POAI), together with its TumorGenesis subsidiary, has achieved significant breakthroughs in applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. Earlier in June, TumorGenesis, which is developing a new rapid approach to growing tumors in the laboratory, sold its first order of unique ovarian cancer cell culture media to a New England-based university carrying out research within the sector (http://nnw.fm/yv6Qj). A recent article discussing POAI and TumorGenesis reads, “Predictive Oncology focuses on building AI-driven predictive models of tumor drug response and outcomes from its database of drug-response and genomic profiles gathered from more than…

ThursdayAug 27, 2020 12:16 pm

NetworkNewsBreaks – InvestorBrandNetwork to Serve as Gold Sponsor for The LD 500

InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and content distributor, today announced that it will continue in its long-term collaboration with LD Micro and serve as a gold sponsor of The LD 500. The event is slated to take place from September 1 – 4 in an entirely digital format. The LD 500 is virtualizing and expanding one of the largest and most influential independent micro-cap conferences, the LD Micro Main Event, and will provide the online investment community with engaging presentations from hundreds of innovative companies within a variety of sectors, including technology, biotech, pharmaceuticals, and alternative energy. This…

ThursdayAug 27, 2020 11:38 am

NetworkNewsBreaks – Allied Esports Entertainment, Inc. (NASDAQ: AESE) Subsidiary & GRID Sign Multiyear Licensing Agreement

Allied Esports, a global esports entertainment company and a subsidiary of Allied Esports Entertainment (NASDAQ: AESE), has inked a deal with GRID, a leading esports data provider. The contract marks the first time Allied Esports has offered the use of data and video rights for the enhancement of regulated consumer betting. The agreement covers the monetization of data and video rights to Allied’s popular Counter-Strike: Global Offensive (“CS:GO”) Legend Series events. Set to launch on Monday, Aug. 31, 2020, with the VIE.gg CS:GO Legend Series tournament, the deal will be integrated into Legend Series events to provide real-time, official data…

ThursdayAug 27, 2020 11:07 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Editorial Projecting Significant Growth for Global Brain Tumor Therapeutics Sector

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, was featured in an editorial by Financial News Media. The piece, titled “Global Brain Tumor Therapeutics Market Targeted to Reach $3.4 Billion by 2025,” covers CNSP and other biotech and pharma companies, including Mallinckrodt plc (NYSE: MNK), Amarin Corporation plc (NASDAQ: AMRN), Merck (NYSE: MRK) and Immunic Inc. (NASDAQ: IMUX), which are active in the market. Several industry analysts project continued growth in the global brain tumor therapeutics sector, with one such report projecting…

ThursdayAug 27, 2020 10:56 am

NetworkNewsBreaks – Karuna Therapeutics, Inc. (NASDAQ: KRTX) Featured in Mizuho Securities Research Report

Karuna Therapeutics (NASDAQ: KRTX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We spoke with several investors as well as company management following the weakness in Karuna shares that followed the announcement that top holder PureTech (Not Covered) has obtained permission from its shareholders to sell its Karuna holdings and that it sold ~$100M worth of Karuna shares through a block trade. Based on our conversation with management and our review of the situation, we remain bullish on Karuna's outlook. We continue to see it as a Top Pick in our…

ThursdayAug 27, 2020 10:30 am

NetworkNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Announces Participation Schedule for September Investor Conferences

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, recently announced its plans to participate in investor conferences during the month of September 2020. According to the update, SGLB will participate in the LD 500 Virtual Investor Conference slated to take place from September 1-4, 2020, and the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020. Sigma Labs CEO Mark K. Ruport will host a virtual presentation and participate in one-on-one meetings, and management will highlight its recent contract award with Mitsubishi Heavy Industries and other end users in a…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks